Eupraxia Pharmaceuticals (EPRX) Non-Current Assets (2022 - 2026)
Eupraxia Pharmaceuticals (EPRX) posted Non-Current Assets of $3.1 million for the quarter ended Jun 30, 2026, up 305.0% from $766,167 a year earlier but down 3.9% from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Non-Current Assets (2022 - 2026) Analysis & Trends
As of Dec 31, 2025, Eupraxia Pharmaceuticals' Non-Current Assets came in at $1.05 million, up 107.9% from the prior year.
- Annual Non-Current Assets shows a three-year compound annual growth rate of 25.4% (years ended Dec 2022 to Dec 2025).
- In prior years, Eupraxia Pharmaceuticals' Non-Current Assets was $505,677 in the year ended Dec 31, 2024 (+9.2%), $463,151 in the year ended Dec 31, 2023 (-13.1%) and $533,242 in the year ended Dec 31, 2022.
- Quarterly Non-Current Assets has run from a low of $420,425 in the quarter ended Mar 31, 2024 to a high of $3.23 million in the quarter ended Mar 31, 2026 over five years.
- On a year-over-year basis, Non-Current Assets has increased in each of the last seven quarters, with growth averaging 150.9% over the last seven quarters.
- The strongest year-over-year quarter for Non-Current Assets in the past five years was the quarter ended Mar 31, 2026, with growth of 415.1%; the weakest was the quarter ended Dec 31, 2023, with a decline of 13.1%.
- According to Business Quant data, Non-Current Assets for the three prior quarters was $3.23 million (quarter ended Mar 31, 2026), $1.05 million (quarter ended Dec 31, 2025) and $949,192 (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Eupraxia Pharmaceuticals | 328.04 Mn | 326.44 Mn | - | 3.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.10 Mn |
| Mar 31, 2026 | 3.23 Mn |
| Dec 31, 2025 | 1.05 Mn |
| Sep 30, 2025 | 949,192.00 |
| Jun 30, 2025 | 766,167.00 |
| Mar 31, 2025 | 626,767.00 |
| Dec 31, 2024 | 505,677.00 |
| Sep 30, 2024 | 474,923.00 |
| Jun 30, 2024 | 450,128.00 |
| Mar 31, 2024 | 420,425.00 |
| Dec 31, 2023 | 463,151.00 |
| Dec 31, 2022 | 533,242.00 |
API Access
Eupraxia Pharmaceuticals Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();